Cambrian Biopharma: Cambrian Bio launches Amplifier Therapeu

The New York based biotech company announces launch of Amplifier Therapeutics to develop the clinical stage pan-AMPK activator, ATX-304 NEW YORK, March 14, 2023 /PRNewswire/ -- Cambrian

Related Keywords

New York , United States , Sweden , Swedish , Dennis Riedl , Thomas Edlund , James Peyer , Helena Edlund , Ruth Thieroff Ekerdt , James Hall , Olof Karlsson , Rosa Argyropoulos , Head Of Cardiovascular Business Development At Astrazeneca , A Distributed Development Company , Linkedin , Global Corporate Communications , Clinical Development , Amplifier Therapeutics , Cardiovascular Business Development , Mechanism Phase , Distributed Development Company , Global Corporate , Cambrian , Iopharma , Aunches , Amplifier , Herapeutics , Evelop , Linical , Stage , Campk , Activator ,